Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Patenting Machine Learning and AI Innovations: Strengthen Your Claims to Avoid Rejection


By Jesse Schwartz
Published: September 19th, 2018

Machine learning and artificial intelligence innovations are quickly becoming commonplace in the life sciences, informatics, automotive, security, and medical device fields just to name a few. Many universities are dedicating research centers and funding dollars to support these inventions, but risks abound in this emerging market and legal landscape — and ensuring valid and enforceable patents is a must.

Already this fast-paced innovation sector has become a hotbed of patent protection controversy. USPTO is providing some guidance, but as is often the case there is room for interpretation — and confusion for patent applicants. As we see with many software claims, the key appears to be in the description.

To help TTOs best protect their growing portfolios of machine learning and AI technologies, Technology Transfer Tactics has tapped Gregory Rabin, senior attorney with law firm Schwegman, Lundberg Woessner, to present the practical webinar Patenting Machine Learning and AI Innovations: Strengthen Your Claims to Avoid Rejection, scheduled for October 16.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

IP Audit Checklist: Best Practices to Identify, Protect, Monetize and Enforce University IP Assets


By Jesse Schwartz
Published: September 12th, 2018

IP audits are essential to properly manage your university’s IP portfolio. To fully understand the commercial potential as well as the risks — in many cases involving hundreds of individual IP assets — a regular and systematic review process is an absolute must. Without it, you could be losing out on significant revenue opportunities, overlooking litigation risks, and missing critical deadlines and filing requirements that could even cost you the rights to that IP.

That’s why Technology Transfer Tactics’ Distance Learning Division has scheduled this detailed program led by a team of expert attorneys from the law firm Offit Kurman: IP Audit Checklist: Best Practices to Identify, Protect, Monetize and Enforce University IP Assets. Join us on September 26th for this practical session that will take you step-by-step through the process and procedures of a general audit, event-driven audit, and limited-purpose IP audit.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

How Notre Dame’s IDEA Center Took University Start-Up Formation from Puny to Powerhouse: A Case Study in Performance Improvement


By Jesse Schwartz
Published: September 5th, 2018

For 175 years, Notre Dame’s start-up statistics were pretty grim: over that period of time, only 33 companies were formed. Fast-forward to 2017 when, under IDEA’s watchful eye, in just a single year they launched 27 companies that raised more than $4 million and created 83 new jobs.

Join us to find out how the IDEA center led this dramatic turnaround to attract record numbers of entrepreneurial-minded students and faculty, and how the school has been transformed from a laggard in start-up formation to a national leader. Technology Transfer Tactics’ Distance Learning Division has teamed up with Notre Dame’s Vice President for Innovation and its Director of Student Entrepreneurship for this detailed case study webinar: How Notre Dame’s IDEA Center Took University Start-Up Formation from Puny to Powerhouse: A Case Study in Performance Improvement, scheduled for Tuesday, September 11.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Encore webinar tomorrow: Drafting Equity Terms for University-Based Start Ups


By Jesse Schwartz
Published: August 29th, 2018

How you structure equity deals with faculty start-ups can have profound effects on both the new venture and the university’s ultimate stake in the fortunes of the company. The wrong moves in the initial license can scare off future investors and dampen the start-up’s prospects for long-term success, but terms that are too favorable for founders and investors can severely reduce the university’s returns when the business reaches a liquidity event.

Striking the right balance is a delicate challenge that requires a full understanding of the financial levers in the deal, and how each party will be impacted as the new venture gains value while taking on new partners — and a more complex cap table. That’s why Tech Transfer Central has scheduled this encore presentation of the highly rated distance learning program Drafting Equity Terms for University-Based Start Ups, to be broadcast tomorrow, August 30 at 11:00 am ET.

For complete program and faculty details or to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

University Technology Marketing Boot Camp on DVD


By Jesse Schwartz
Published: August 29th, 2018

Technology and licensing managers often are well-versed in a wide range of technical and scientific fields, have an excellent grasp of IP law, and have a good handle on business and financial issues too. But when it comes to marketing, they are often at a near-total loss.

By focusing on shoring up this critical but often neglected area of professional development, your TTO will reap huge dividends in its ability to attract the licensees, investors, entrepreneurs, and partners you need. The University Technology Marketing Boot Camp is a four-program collection featuring university technology marketing experts who will lead you in making critical improvements in your marketing approaches and strategies. The four session topics are:

Session One: Understanding Your Technology, Inventor and Market

Session Two: Marketing Writing Best Practices

Session Three: Marketing by Channel

Session Four: Content Strategy and Analytics

For complete program and faculty details, CLICK HERE.

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Webinar next week: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: August 15th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments.

That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi, scheduled for next Thursday, August 23rd.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: August 8th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments. That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

International Collaborations and IP Protection


By Jesse Schwartz
Published: August 8th, 2018

To help universities tap into the growing international opportunities for research partnerships — while also ensuring key issues surrounding IP and other contract terms are appropriately addressed — Technology Transfer Tactics’ Distance Learning Division has created International Collaborations and IP Protection, an exclusive collection containing over three hours of expert advice, immediately implementable takeaways, and cost-saving solutions on this critical topic.

Here’s what’s included in this high-value collection.

  • Session One: Best Practices for Safeguarding University IP When Structuring Deals in China
  • Session Two: Building International Sponsored Research Collaborations: Navigating Culture, Contracting, Compliance, and IP Protection
  • Session Three: Best Practices for Cost-Effective Filing of PCT and EPO Patent Applications

For complete program and faculty details and to order, CLICK HERE >>

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Next Week — Open Source Licensing: Risks and Opportunities for University Innovations


By Jesse Schwartz
Published: August 1st, 2018

As TTOs see larger portions of their portfolios occupied by mobile apps, software, and other innovations that build on existing technologies, it’s become critical to gain a solid grasp of the often misunderstood world of open source licensing. It’s a world that is often accompanied by a myriad of risks as well as opportunities.

On the risk side, about half of the code used in all software, including IoT devices, is open source, with dozens of different licensing terms and obligations. And penalties for failure to comply can be severe, including a complete restriction on selling a product incorporating the open source component.

Then there’s the opportunity side — where a growing number of companies are building big valuations using open source business models. There’s a lot to learn, and a lot at stake — that’s why Tech Transfer Central’s Distance Learning Division has scheduled the detailed webinar Open Source Licensing: Risks and Opportunities for University Innovations, coming August 7th.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: July 25th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Disclosure of target antigens without the antibody disclosure will no longer cut it.

And because what constitutes a “sufficient” number is unclear, universities that don’t have the resources to characterize a large number of antibodies before applying for a patent face a significant challenge. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments. That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi, scheduled for August 23rd.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Protecting and Licensing University Patents in a Post-Oil States and SAS World


By Jesse Schwartz
Published: July 18th, 2018

With its decision in Oil States, the Supreme Court affirmed the Constitutionality of PTAB’s inter partes reviews, but in a simultaneous decision in SAS Institute, it also changed the rulebook for IPR decision-making — changes that have profound ramifications for the entire U.S. patent system – and universities in particular. At the same time, the U.S. Patent Office is changing the standard for how PTAB evaluates claims, moving to the “usual and customary meaning” standard in line with federal courts.

There’s a lot to unpack and digest from these rulings and changes, and they bring both good news and bad — along with plenty of uncertainty — for university TTOs. What do these decisions really mean? How should TTOs adjust their filing strategies to protect their patents? How will the changes affect licensing activity? Will PTAB challenges be more or less likely?

To answer those questions and more, Technology Transfer Tactics’ Distance Learning Division has secured a team of patent attorneys from the law firm Harness, Dickey & Pierce, PLC, who deal with post-grant proceedings on a regular basis, and technology transfer leaders from NUtech Ventures, who will provide the insight and guidance you need to react effectively to the changes. Join us July 25th for this critical webinar: Protecting and Licensing University Patents in a Post-Oil States and SAS World. For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Next week: Webinar on compliance with 2018 Bayh-Dole revisions


By Jesse Schwartz
Published: July 11th, 2018

Important revisions to the Bayh-Dole Act have now taken effect, and it’s critical for universities to ensure their compliance procedures are addressing the new rules. From changes in the abandonment and conversion processes to the impact on internal systems and procedures as well as communications with licensees, adjusting to the new rules represents a significant challenge. But it’s a challenge that can be met and even bring improvements to TTO and research compliance operations if handled with a strong training component and a clear, detailed operational plan.

To help ensure a smooth transition and full compliance, Tech Transfer Central’s Distance Learning Division has secured an expert team from law firm Amster, Rothstein & Ebenstein LLP to lead a critical webinar, The 2018 Bayh Dole Revisions: Practical Compliance Guidance for Technology Transfer Offices, scheduled next Tuesday, July 17.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News